EU patents approved for Quantum

18 March 2021

Quantum is ValitaCell's pioneering technology that powers a range of products including VALITA®TITER. Innovation and the creation of 'new to world' technologies is central to ValitaCell's culture. The creation and IP protection of our technologies is a key competitive advantage for our business and we are delighted that the EU has recognised the uniqueness of Quantum with an additional two patents.

The awarded patents are:

European patent No. 3170004. 'A method of measuring antibody concentration in a sample'

European patent No. 3391049. 'A method of determining the abundance of a target molecule in a sample'